<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39497750</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2813-0626</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in nephrology</Title><ISOAbbreviation>Front Nephrol</ISOAbbreviation></Journal><ArticleTitle>The clinical course of SARS-CoV-2 infection in patients with glomerular diseases and evaluation of the subsequent risk of relapse.</ArticleTitle><Pagination><StartPage>1472294</StartPage><MedlinePgn>1472294</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1472294</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneph.2024.1472294</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">This study aimed to describe the clinical course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with glomerular diseases (GDs) and its impact on the probability of relapse.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients with biopsy-proven GD and positive PCR test for SARS-CoV-2 from glomerular clinics across Greece were studied retrospectively. Those who received the GD diagnosis after the SARS-CoV-2 vaccination or coronavirus disease 2019 (COVID-19) or ended in ESKD prior to infection were excluded. Demographics, histopathological diagnoses, past medical history, immunosuppression, and GD activity status were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 219 patients with GDs and documented SARS-CoV-2 infection were included. The mean time from the diagnostic kidney biopsy to SARS-CoV-2 infection was 67.6 ( &#xb1; 59.3) months. Among the participants, 82.5% had been vaccinated against SARS-CoV-2 with three doses (range: 2.5-3) without subsequent GD reactivation in 96.2% of them. Twenty-two patients (10%) were hospitalized for COVID-19 and one (0.5%) required mechanical ventilation. Four (1.8%) died due to COVID-19 and one (0.5%) had long COVID-19 symptoms. Among patients in remission prior to SARS-CoV-2 infection, 22 (11.2%) experienced a GD relapse within 2.2 (range: 1.5-3.7) months from the diagnostic test. The relapse-free survival after COVID-19 was significantly shorter for patients with minimal change disease, pauci-immune glomerulonephritis, and focal segmental glomerulosclerosis. No difference was observed in the relapse-free survival post-COVID-19 based on the history of SARS-CoV-2 vaccination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">SARS-CoV-2 infection appears to have a symptomatic but uncomplicated sequence in vaccinated patients with GDs, with a significant impact on the clinical course of GD, associated with an increased probability of relapse in certain histopathological types.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Lionaki, Dounousi, Marinaki, Kantartzi, Papasotiriou, Galitsiou, Bellos, Sardeli, Kalogeropoulos, Liakopoulos, Mpintas, Goumenos, Flouda, Venetsanopoulou, Voulgari, Andronikidi, Moustakas, Panagoutsos and Boletis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lionaki</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, 2nd Department of Propaedeutic Internal Medicine, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dounousi</LastName><ForeName>Evangelia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Nephrology, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinaki</LastName><ForeName>Smaragdi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Renal Transplantation, Laiko General Hospital, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kantartzi</LastName><ForeName>Konstantia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papasotiriou</LastName><ForeName>Marios</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Renal Transplantation, University Hospital of Patras, Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galitsiou</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Peripheral General Hospital Athens Giorgos Gennimatas, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Renal Transplantation, Laiko General Hospital, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardeli</LastName><ForeName>Aggeliki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Nephrology, 2nd Department of Propaedeutic Internal Medicine, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalogeropoulos</LastName><ForeName>Petros</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Nephrology, 2nd Department of Propaedeutic Internal Medicine, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liakopoulos</LastName><ForeName>Vassilios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>2nd Department of Nephrology, AHEPA University Hospital, Medical school, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mpintas</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Renal Transplantation, Laiko General Hospital, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goumenos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Renal Transplantation, University Hospital of Patras, Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flouda</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>4th Department of Internal Medicine, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venetsanopoulou</LastName><ForeName>Aliki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voulgari</LastName><ForeName>Paraskevi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andronikidi</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Aretaieio Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moustakas</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Peripheral General Hospital Athens Giorgos Gennimatas, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagoutsos</LastName><ForeName>Stylianos</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boletis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinic of Nephrology and Renal Transplantation, Laiko General Hospital, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nephrol</MedlineTA><NlmUniqueID>9918469487906676</NlmUniqueID><ISSNLinking>2813-0626</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">glomerulonephritis</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">podocytopathies</Keyword><Keyword MajorTopicYN="N">relapse</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>10</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39497750</ArticleId><ArticleId IdType="pmc">PMC11532109</ArticleId><ArticleId IdType="doi">10.3389/fneph.2024.1472294</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gandhi RT, Lynch JB, Del Rio C. Mild or moderate covid-19. N Engl J Med. (2020) 383:1757&#x2013;66. doi:&#xa0;10.1056/NEJMcp2009249</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet. (2020) 395:1382&#x2013;93. doi:&#xa0;10.1016/S0140-6736(20)30746-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30746-7</ArticleId><ArticleId IdType="pmc">PMC7195331</ArticleId><ArticleId IdType="pubmed">32277878</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadoun D, Vieira M, Vautier M, Baraliakos X, Andreica I, da Silva JAP, et al. . SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study. Lancet Rheumatol. (2021) 3:e481&#x2013;8. doi:&#xa0;10.1016/S2665-9913(21)00112-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00112-0</ArticleId><ArticleId IdType="pmc">PMC8081401</ArticleId><ArticleId IdType="pubmed">33942031</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. . A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. (2020) 98:20&#x2013;6. doi:&#xa0;10.1016/j.kint.2020.04.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.04.030</ArticleId><ArticleId IdType="pmc">PMC7206428</ArticleId><ArticleId IdType="pubmed">32437768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson BL. Unraveling the immunopathogenesis of glomerular disease. Clin Immunol. (2016) 169:89&#x2013;97. doi:&#xa0;10.1016/j.clim.2016.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.06.011</ArticleId><ArticleId IdType="pubmed">27373970</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrisc&#x103; B, Vornicu A, Jurubit&#x103; R, Achim C, Bobeic&#x103; R, Andronesi A, et al. . Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement. Clin Rheumatol. (2021) 40:3285&#x2013;97. doi:&#xa0;10.1007/s10067-021-05646-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05646-2</ArticleId><ArticleId IdType="pubmed">33595739</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenn DA, Henderson CD, O&#x2019;Shaughnessy M, Hu Y, Bomback A, Gibson K, et al. . Infection- related acute care events among patients with glomerular disease. Clin J Am Soc Nephrol. (2020) 15:1749&#x2013;61. doi:&#xa0;10.2215/CJN.05900420</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05900420</ArticleId><ArticleId IdType="pmc">PMC7769021</ArticleId><ArticleId IdType="pubmed">33082200</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. (2021) 80:384&#x2013;91. doi:&#xa0;10.1136/annrheumdis-2020-218946</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218946</ArticleId><ArticleId IdType="pubmed">33051220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, et al. . Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, march 2020-march 2021. Prev Chronic Dis. (2021) 18:E66. doi:&#xa0;10.5888/pcd18.210123</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd18.210123</ArticleId><ArticleId IdType="pmc">PMC8269743</ArticleId><ArticleId IdType="pubmed">34197283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko JY, Danielson ML, Town M, Derado G, Greenlund KJ, Kirley PD, et al. . Risk factors for coronavirus disease 2019 (COVID-19)-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system. Clin Infect Dis. (2021) 72:e695&#x2013;703. doi:&#xa0;10.1093/cid/ciaa1419</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1419</ArticleId><ArticleId IdType="pmc">PMC7543371</ArticleId><ArticleId IdType="pubmed">32945846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan NC, Weitz JI. COVID-19 coagulopathy, thrombosis, and bleeding. Blood. (2020) 136:381&#x2013;3. doi:&#xa0;10.1182/blood.2020007335</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007335</ArticleId><ArticleId IdType="pmc">PMC7378461</ArticleId><ArticleId IdType="pubmed">32702124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremoni M, Benzaken S, Zorzi K, Fernandez C, Esnault V, Barri&#xe8;re J, et al. . Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease. Nephrol Dialysis Transplant. (2023) 38:249&#x2013;51. doi:&#xa0;10.1093/ndt/gfac294</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfac294</ArticleId><ArticleId IdType="pubmed">36352472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CM, Gupta S, Tighiouart H, Goyal N, Faugno AJ, Tariq A, et al. . Kidney recovery and death in critically ill patients with COVID-19-associated acute kidney injury treated with dialysis: the STOP-COVID cohort study. Am J Kidney Dis. (2022) 79:404&#x2013;416.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641974</ArticleId><ArticleId IdType="pubmed">34871701</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasr SH, Kopp JB. COVID-19-associated collapsing glomerulopathy: an emerging entity. Kidney Int Rep. (2020) 5:759&#x2013;61. doi:&#xa0;10.1016/j.ekir.2020.04.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2020.04.030</ArticleId><ArticleId IdType="pmc">PMC7196556</ArticleId><ArticleId IdType="pubmed">32368701</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, et al. . American college of rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 3. Arthritis Rheumatol. (2021) 73:e1&#x2013;12. doi:&#xa0;10.1002/art.41596</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41596</ArticleId><ArticleId IdType="pubmed">33277981</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders HJ, Bruchfeld A, Fernandez Juarez GM, Floege J, Goumenos D, Turkmen K, et al. . Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic. Nephrol Dial Transplant. (2020) 35:920&#x2013;5. doi:&#xa0;10.1093/ndt/gfaa112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfaa112</ArticleId><ArticleId IdType="pmc">PMC7313759</ArticleId><ArticleId IdType="pubmed">32445573</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group . Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. (2021) 100:S1&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">34556256</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. . A new equation to estimate glomerular filtration rate. Ann Intern Med. (2009) 150:604&#x2013;12. doi:&#xa0;10.7326/0003-4819-150-9-200905050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau T. A package for survival analysis in R. Copyright 2000 Mayo Foundation for Medical Education and Research. (2024).</Citation></Reference><Reference><Citation>Kassambra A, Kosinski M, Biecek P. Package &#x201c;survminer&#x201d; Type package title drawing survival curves using &#x201c;ggplot2.&#x201d;2021. (2021).</Citation></Reference><Reference><Citation>Wang CS, Doma R, Westbrook AL, Johnson J, Anderson EJ, Greenbaum LA, et al. . Vaccine attitudes and COVID-19 vaccine intention among parents of children with kidney disease or primary hypertension. Am J Kidney Dis. (2023) 81:25&#x2013;35.e1. doi:&#xa0;10.1053/j.ajkd.2022.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC9212850</ArticleId><ArticleId IdType="pubmed">35750280</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner-Stokes T, Jiang E, Johnson N, Khakhria K, Kong E, Cairns T, et al. . Serologic screening for coronavirus disease 2019 in patients with glomerular disease. Kidney Int Rep. (2021) 6:1402&#x2013;6. doi:&#xa0;10.1016/j.ekir.2021.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ekir.2021.02.006</ArticleId><ArticleId IdType="pmc">PMC7879059</ArticleId><ArticleId IdType="pubmed">33615050</ArticleId></ArticleIdList></Reference><Reference><Citation>Eidininkien&#x117; M, Cesarskaja J, Tala&#x10d;kait&#x117; S, Tra&#x161;kait&#x117;-Ju&#x161;kevi&#x10d;ien&#x117; V, Macas A. Mini review: co-existing diseases and COVID-19-A one way ticket? Int J Environ Res Public Health. (2022) 19:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9029116</ArticleId><ArticleId IdType="pubmed">35457604</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti M, Rinaldi M, Bussini L, Bonazzetti C, Pascale R, Pasquini Z, et al. . Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28:1057&#x2013;65. doi:&#xa0;10.1016/j.cmi.2022.02.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.039</ArticleId><ArticleId IdType="pmc">PMC8916831</ArticleId><ArticleId IdType="pubmed">35289294</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Wada N, Murakami H, Funaki S, Inagaki T, Harada K, et al. . Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol. (2007) 22:232&#x2013;6. doi:&#xa0;10.1007/s00467-006-0316-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-006-0316-y</ArticleId><ArticleId IdType="pubmed">17043884</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimmel A, Shaikhouni S, Mariani L. Current understanding of clinical manifestations of COVID-19 in glomerular disease. Glomerular Dis. (2021) 1:250&#x2013;64. doi:&#xa0;10.1159/000518276</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518276</ArticleId><ArticleId IdType="pmc">PMC8450860</ArticleId><ArticleId IdType="pubmed">36747902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron JS. Nephrotic syndrome in the elderly. Semin Nephrol. (1996) 16:319&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">8829270</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. (2002) 39:503&#x2013;12. doi:&#xa0;10.1053/ajkd.2002.31400</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2002.31400</ArticleId><ArticleId IdType="pubmed">11877569</ArticleId></ArticleIdList></Reference><Reference><Citation>Korbet SM, Schwartz MM, Lewis EJ. Minimal-change glomerulopathy of adulthood. Am J Nephrol. (1988) 8:291&#x2013;7. doi:&#xa0;10.1159/000167603</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000167603</ArticleId><ArticleId IdType="pubmed">3189423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang Z, Dong L, Guo Y, Wu J, Zhai S. New insight into the pathogenesis of minimal change nephrotic syndrome: Role of the persistence of respiratory tract virus in immune disorders. Autoimmun Rev. (2016) 15:632&#x2013;7. doi:&#xa0;10.1016/j.autrev.2016.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2016.02.007</ArticleId><ArticleId IdType="pubmed">26876386</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, et al. . Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases. BMC Nephrol. (2018) 19:331. doi:&#xa0;10.1186/s12882-018-1132-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-018-1132-x</ArticleId><ArticleId IdType="pmc">PMC6247501</ArticleId><ArticleId IdType="pubmed">30458703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahali D, Sendeyo K, Mangier M, Audard V, Zhang SY, Lang P, et al. . Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol. (2014) 36:421&#x2013;9. doi:&#xa0;10.1007/s00281-013-0415-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-013-0415-3</ArticleId><ArticleId IdType="pmc">PMC5385209</ArticleId><ArticleId IdType="pubmed">24402710</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama M, Sugimoto T, Yokono T, Sakaguchi M, Deji N, Uzu T, et al. . Minimal-change nephropathy and chronic hepatitis C infection: coincidental or associated? Nephrol Dial Transplant. (2007) 22:1479&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">17210595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou TB, Jiang ZP. Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report. Ren Fail. (2015) 37:459&#x2013;61. doi:&#xa0;10.3109/0886022X.2014.1001711</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2014.1001711</ArticleId><ArticleId IdType="pubmed">25585950</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE, Wolfish N, McLaine P, Phipps P, Rossier E. Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr. (1986) 108:378&#x2013;82. doi:&#xa0;10.1016/S0022-3476(86)80876-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(86)80876-9</ArticleId><ArticleId IdType="pubmed">3005537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachman PH. Primary glomerular disease. Kidney. N Engl J Med (2008) 377(24):2363&#x2013;2374.</Citation></Reference><Reference><Citation>Cohen SD, Kopp JB, Kimmel PL. Kidney diseases associated with human immunodeficiency virus infection. N Engl J Med. (2017) 377:2363&#x2013;74. doi:&#xa0;10.1056/NEJMra1508467</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1508467</ArticleId><ArticleId IdType="pubmed">29236630</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol. (2015) 11:150&#x2013;60. doi:&#xa0;10.1038/nrneph.2015.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.9</ArticleId><ArticleId IdType="pubmed">25686569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross MJ. Advances in the pathogenesis of HIV-associated kidney diseases. Kidney Int. (2014) 86:266&#x2013;74. doi:&#xa0;10.1038/ki.2014.167</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2014.167</ArticleId><ArticleId IdType="pubmed">24827777</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott J, Hartnett J, Mockler D, Little MA. Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review. Autoimmun Rev. (2020) 19:102660. doi:&#xa0;10.1016/j.autrev.2020.102660</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102660</ArticleId><ArticleId IdType="pubmed">32947040</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz G, Wallace ZS. Environmental triggers for vasculitis. Rheum Dis Clin North Am. (2022) 48:875&#x2013;90. doi:&#xa0;10.1016/j.rdc.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2022.06.008</ArticleId><ArticleId IdType="pubmed">36333001</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk RJ. ANCA-associated renal disease. Kidney Int. (1990) 38:998. doi:&#xa0;10.1038/ki.1990.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1990.304</ArticleId><ArticleId IdType="pubmed">2266686</ArticleId></ArticleIdList></Reference><Reference><Citation>Draibe J, Rod&#xf3; X, Fulladosa X, Mart&#xed;nez-Valenzuela L, Diaz-Encarnaci&#xf3;n M, Santos L, et al. . Seasonal variations in the onset of positive and negative renal ANCA-associated vasculitis in Spain. Clin Kidney J. (2018) 11:468&#x2013;73. doi:&#xa0;10.1093/ckj/sfx127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfx127</ArticleId><ArticleId IdType="pmc">PMC6070110</ArticleId><ArticleId IdType="pubmed">30094010</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener&#x2019;s granulomatosis&#x2013;increased incidence or increased recognition? Br J Rheumatol. (1996) 35:142&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8612026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, et al. . ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol. (2015) 26:537&#x2013;42. doi:&#xa0;10.1681/ASN.2013111233</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013111233</ArticleId><ArticleId IdType="pmc">PMC4341475</ArticleId><ArticleId IdType="pubmed">25324502</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen Tervaert JW, Damoiseaux J. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up? Clin Rev Allergy Immunol. (2012) 43:211&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22669754</ArticleId></ArticleIdList></Reference><Reference><Citation>Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, et al. . Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol. (2005) 167:47&#x2013;58. doi:&#xa0;10.1016/S0002-9440(10)62952-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)62952-5</ArticleId><ArticleId IdType="pmc">PMC1603449</ArticleId><ArticleId IdType="pubmed">15972951</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemna MJ, Cohen Tervaert JW, Broen K, Timmermans SAMEG, van Paassen P, Damoiseaux JGMC. Seasonal influence on the risk of relapse at a rise of antineutrophil cytoplasmic antibodies in vasculitis patients with renal involvement. J Rheumatol. (2017) 44:473&#x2013;81. doi:&#xa0;10.3899/jrheum.160066</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.160066</ArticleId><ArticleId IdType="pubmed">28202741</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>